MedDataX Logo

Relation Between Intrabdominal Pressure and Collapsibility Index of Inferior Vena Cava Before and After Fluid Therapy

NCT ID: NCT01553422

Last Updated: 2012-12-04

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

PHASE4

Total Enrollment

82 participants

Study Classification

INTERVENTIONAL

Study Start Date

2012-03-31

Study Completion Date

2012-11-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This study assess the relation between intra abdominal pressure and collapsibility index of inferior vena cava in emergency bedside ultrasonography before and after fluid therapy.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Abdominal Compartment Syndrome

Keywords

Explore important study keywords that can help with search, categorization, and topic discovery.

Intrabdominal Pressure Emergency Bedside Ultrasonography Abdominal Compartment Syndrome

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NON_RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

DIAGNOSTIC

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

before fluid Therapy

Group Type ACTIVE_COMPARATOR

Fluid therapy (Saline Normal)

Intervention Type OTHER

Saline Normal 1 Lit. during 30 minutes

after fluid Therapy

Group Type ACTIVE_COMPARATOR

Fluid therapy (Saline Normal)

Intervention Type OTHER

saline Normal 1 lit during 30 minutes

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Fluid therapy (Saline Normal)

Saline Normal 1 Lit. during 30 minutes

Intervention Type OTHER

Fluid therapy (Saline Normal)

saline Normal 1 lit during 30 minutes

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Body Mass index less than 30
* Written agree of the patient to participate in the study

Exclusion Criteria

* neurogenic bladder or any documented previous surgery on bladder, spastic or contractile bladder
* large abdominal hernia
* patients who received neuromuscular blocking agents
* Patients with abdominal respiration due to chest pain
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Isfahan University of Medical Sciences

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Keihan Golshani

Assistant Professor of Emergency Medicine, Director of Emergency Medicine Residency Program

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

KEIHAN GOLSHANI, M.D.

Role: STUDY_CHAIR

Isfahan University of Medical Sciences

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Emergency department, Alzahra General Hospital

Isfahan, Isfahan, Iran

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Iran

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

390331

Identifier Type: -

Identifier Source: org_study_id